Intrahepatic cholangiocarcinoma trends and treatment lines: real-world evidence from the French National Hospital Discharge database
This study provides up-to-date national real-world data on iCCA, revealing an increasing burden year by year in France, a poor outcome of patients with iCCA on L1 systemic therapy, and the low proportion of patients receiving an L2.
Authors
- Cindy Neuzillet (ORCID: https://orcid.org/0000-0001-7037-7477)
- B. Grenier
- Astrid Lièvre (ORCID: https://orcid.org/0000-0003-2118-717X)
- Matthieu Delaye (ORCID: https://orcid.org/0000-0002-2435-4757)
Institutions
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Oncogenesis Stress Signaling (FR)
- Health Services and Performance Research Laboratory (FR)
- Institut Curie (FR)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1016/j.esmogo.2025.100152
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Servier
- Institut de Recherches Servier